These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9661588)

  • 41. Hormones and bones.
    Rizzoli R; Bonjour JP
    Lancet; 1997 Mar; 349 Suppl 1():sI20-3. PubMed ID: 9057775
    [No Abstract]   [Full Text] [Related]  

  • 42. Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se?
    Bagger YZ; Rasmussen HB; Alexandersen P; Werge T; Christiansen C; Tankó LB;
    Osteoporos Int; 2007 Apr; 18(4):505-12. PubMed ID: 17109061
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk factors and prevention of osteoporosis-related fractures.
    Dontas IA; Yiannakopoulos CK
    J Musculoskelet Neuronal Interact; 2007; 7(3):268-72. PubMed ID: 17947811
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HRT in the prevention and treatment of osteoporosis.
    Delmas PD
    J Epidemiol Biostat; 1999; 4(3):155-60; discussion 160-3. PubMed ID: 10695957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The waning effect of postmenopausal estrogen therapy on osteoporosis.
    Ettinger B; Grady D
    N Engl J Med; 1993 Oct; 329(16):1192-3. PubMed ID: 8377785
    [No Abstract]   [Full Text] [Related]  

  • 46. [Hypogonadism and osteoporosis].
    Chaki O
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():693-701. PubMed ID: 15035211
    [No Abstract]   [Full Text] [Related]  

  • 47. [Postmenopausal osteoporosis].
    Miki T; Tamura A
    Nihon Rinsho; 2006 Jun; Suppl 2():81-6. PubMed ID: 16817356
    [No Abstract]   [Full Text] [Related]  

  • 48. Bone mass measurement and factors associated with risk of fracture in a group of peri- and postmenoupausal women.
    Rasheed A; Khurshid R; Aftab L
    J Ayub Med Coll Abbottabad; 2008; 20(1):48-51. PubMed ID: 19024185
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Inhibition of progression of decreasing bone mass and manifest osteoporosis].
    Ringe JD
    Internist (Berl); 1993 Apr; 34(4):300-6. PubMed ID: 8486473
    [No Abstract]   [Full Text] [Related]  

  • 50. Reduced bone mass and increased bone turnover in postmenopausal women with epilepsy using antiepileptic drug monotherapy.
    Lyngstad-Brechan MA; Taubøll E; Nakken KO; Gjerstad L; Godang K; Jemtland R; Bollerslev J
    Scand J Clin Lab Invest; 2008; 68(8):759-66. PubMed ID: 18618370
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dietary protein and bone health.
    Rizzoli R; Bonjour JP
    J Bone Miner Res; 2004 Apr; 19(4):527-31. PubMed ID: 15005837
    [No Abstract]   [Full Text] [Related]  

  • 52. Bone density vs bone quality: what's a clinician to do?
    Licata A
    Cleve Clin J Med; 2009 Jun; 76(6):331-6. PubMed ID: 19487553
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Osteoporosis workup: evaluating bone loss and risk of fractures.
    Murray C; O'Brien K
    Geriatrics; 1995 Sep; 50(9):41-6, 53; quiz 54-5. PubMed ID: 7672617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of estrogen on bone in the human male: insights from the natural models of congenital estrogen deficiency.
    Rochira V; Balestrieri A; Faustini-Fustini M; Carani C
    Mol Cell Endocrinol; 2001 Jun; 178(1-2):215-20. PubMed ID: 11403912
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of grip strength change with menopausal bone loss and related fractures: a population-based follow-up study.
    Sirola J; Rikkonen T; Tuppurainen M; Jurvelin JS; Kröger H
    Calcif Tissue Int; 2006 Apr; 78(4):218-26. PubMed ID: 16604281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical risk factors for fracture in postmenopausal osteoporotic women: a review of the recent literature.
    LaFleur J; McAdam-Marx C; Kirkness C; Brixner DI
    Ann Pharmacother; 2008 Mar; 42(3):375-86. PubMed ID: 18230704
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular disease and osteoporosis.
    Baldini V; Mastropasqua M; Francucci CM; D'Erasmo E
    J Endocrinol Invest; 2005; 28(10 Suppl):69-72. PubMed ID: 16550727
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The treatment of osteoporosis. Antiresorptive therapy.
    Miller PD
    Clin Lab Med; 2000 Sep; 20(3):603-22, viii. PubMed ID: 10986624
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estrogen and bone.
    Orimo H; Shiraki M; Inoue S
    Osteoporos Int; 1993; 3 Suppl 1():153-6. PubMed ID: 8461546
    [No Abstract]   [Full Text] [Related]  

  • 60. Fourier transform infrared analysis and bone.
    Paschalis EP
    Osteoporos Int; 2009 Jun; 20(6):1043-7. PubMed ID: 19340508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.